Olmesartan medoxomil and Ergocalciferol drug interactions - from FDA reports


Drug interactions are reported among people who take Olmesartan medoxomil and Ergocalciferol together. This study is created by eHealthMe based on reports of 44 people who take Olmesartan medoxomil and Ergocalciferol from FDA, and is updated regularly.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.



On Aug, 10, 2018

44 people who take Olmesartan medoxomil, Ergocalciferol are studied.


Number of reports submitted per year:

Olmesartan medoxomil and Ergocalciferol drug interactions.

Most common drug interactions over time *:

2 - 5 years:
  1. Gastritis (inflammation of stomach)
  2. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Weight decreased
not specified:
  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  2. Tooth loss
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Tympanic membrane perforation (a break in continuity of ear drum)
  5. Pain in extremity
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Pyrexia (fever)
  8. Urinary tract infection
  9. Bone erosion
  10. Diarrhoea
Personalize this study to your gender and age

Most common drug interactions by gender *:

female:
  1. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  2. Mitral valve prolapse (heart's mitral valve doesn't work well)
  3. Muscle atrophy (a decrease in the mass of the muscle)
  4. Muscle spasms (muscle contraction)
  5. Muscle twitching
  6. Muscular weakness (muscle weakness)
  7. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  8. Nicotine dependence
  9. Oropharyngeal pain
  10. Palpitations (feelings or sensations that your heart is pounding or racing)
male:
  1. Abscess limb (limb infection)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  3. Staphylococcal bacteraemia (a bacterial infection of blood)
  4. Stress
  5. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
  6. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
  7. Disability
  8. Abscess (pus)
  9. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
  10. Arthralgia (joint pain)
Subscribe to monitor Olmesartan medoxomil and Ergocalciferol

Most common drug interactions by age *:

30-39:
  1. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
  2. Crohn's disease (condition that causes inflammation of the gastrointestinal tract)
50-59:
  1. Fatigue (feeling of tiredness)
  2. Abscess limb (limb infection)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Drug ineffective
  5. Furuncle (infection of the hair follicle)
  6. Immunosuppression
  7. Lower respiratory tract infection
  8. Obesity (a medical condition in which excess body fat)
  9. Psoriasis (immune-mediated disease that affects the skin)
  10. Staphylococcal abscess (pus formation due to staphylococcal bacteria)
60+:
  1. Electrocardiogram t wave abnormal
  2. Exostosis (formation of new bone on the surface of a bone)
  3. Femur fracture
  4. Gastritis (inflammation of stomach)
  5. Haemoglobin decreased
  6. Haemoglobin increased
  7. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  8. Hospitalisation
  9. Hyperhidrosis (abnormally increased sweating)
  10. Hyperlipidaemia (presence of excess lipids in the blood)
Click here to get more results

* Approximation only. Some reports may have incomplete information.

Are you new to Olmesartan medoxomil and Ergocalciferol or have questions?

Volunteer or get paid to help people with your care experience



Related studies

Olmesartan medoxomil

Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. (latest outcomes from Olmesartan medoxomil 6,116 users)

Ergocalciferol

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. (latest outcomes from Ergocalciferol 6,359 users)


Interactions between Olmesartan medoxomil and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Ergocalciferol and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Olmesartan medoxomil and Ergocalciferol
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Olmesartan medoxomil and Ergocalciferol

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Olmesartan medoxomil, Ergocalciferol

Recent updates

General studies

You could also:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.